The investment report on Medco Health Solutions Inc. (NYSE:MHS) should be of particular interest to companies in the healthcare industry: CVS Caremark Corp. (NYSE:CVS), Express Scripts Inc. (Nasdaq:ESRX), WellPoint Inc. (NYSE:WLP) and Rite Aid Corp. (NYSE:RAD).

It is available at: http://investorsoup.com/lp/MHS/

Read and post on Twitter and top Stock Message Boards for these stocks and more, all in real-time: http://www.BoardCentral.com/

Medco Health Solutions Inc. (MHS) is a healthcare company that provides clinically driven pharmacy services for approximately 60 million Americans. MHS' services are designed to lower total healthcare costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by the Medicare Part D Prescription Drug Plans. The Company provides pharmacy benefit management (PBM) services through its national networks of retail pharmacies and its own mail-order pharmacies.

In the report, the analyst notes:

"For the first quarter of fiscal 2009, MHS' net revenues rose 14.4% to $14.83 billion from $12.96 billion in the previous-year quarter, primarily as a result of contributions from significant new client wins and price inflation on brand-name drugs, partially offset by higher volumes of lower-priced generic drugs. The Company reported a net income of $291 million or $0.58 per share, compared to $270.2 million, or $0.50 per share, in the year-ago quarter.

"Contracts worth $8.6 billion have been completed in 2009. Those deals are expected to bring $7 billion in net new revenue. Beginning January 1, 2009, MHS is administering the Medicare Part D prescription drug benefit on behalf of Coventry Health Care - the sixth largest U.S. health insurer by market value - for 1.2 million Medicare beneficiaries with annual drug spending of more than $2 billion."

To read the entire report visit: http://investorsoup.com/lp/MHS/

InvestorSoup.com is a small-cap research and investment commentary provider. InvestorSoup strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on InvestorSoup, please visit http://www.InvestorSoup.com

InvestorSoup Disclosure

InvestorSoup.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. InvestorSoup.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, InvestorSoup.com, for complete risks and disclosures.

This news release was distributed by GlobeNewswire, www.globenewswire.com

 CONTACT:  InvestorSoup.com           Jeffrey Brown, Editor           (469)-252-3505           info@investorsoup.com 

A service of YellowBrix, Inc.